STACEY PEREIRA to Neonatal Screening
This is a "connection" page, showing publications STACEY PEREIRA has written about Neonatal Screening.
Connection Strength
2.261
-
Psychosocial Effect of Newborn Genomic Sequencing on Families in the BabySeq Project: A Randomized Clinical Trial. JAMA Pediatr. 2021 11 01; 175(11):1132-1141.
Score: 0.635
-
Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project. Pediatrics. 2019 01; 143(Suppl 1):S6-S13.
Score: 0.522
-
Commercial Interests, the Technological Imperative, and Advocates: Three Forces Driving Genomic Sequencing in Newborns. Hastings Cent Rep. 2018 Jul; 48 Suppl 2:S43-S44.
Score: 0.504
-
Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. Genet Med. 2019 03; 21(3):622-630.
Score: 0.128
-
The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018 07 09; 18(1):225.
Score: 0.126
-
Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017 Feb; 139(2).
Score: 0.114
-
Potential Psychosocial Risks of Sequencing Newborns. Pediatrics. 2016 Jan; 137 Suppl 1:S24-9.
Score: 0.106
-
The BabySeq Project: A clinical trial of genome sequencing in a diverse cohort of infants. Am J Hum Genet. 2024 Oct 03; 111(10):2094-2106.
Score: 0.048
-
Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. Am J Hum Genet. 2023 07 06; 110(7):1034-1045.
Score: 0.044
-
Returning a Genomic Result for an Adult-Onset Condition to the Parents of a Newborn: Insights From the BabySeq Project. Pediatrics. 2019 01; 143(Suppl 1):S37-S43.
Score: 0.033